| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.32B | +7.5% |
| R&D Expense | $347.6M | +12.3% |
| SG&A Expense | $3.74B | +4.5% |
| Operating Income | $3.97B | +13.4% |
| Interest Expense | $226.7M | -4.9% |
| Pre-tax Income | $3.68B | +13.5% |
| Income Tax | $705.9M | +12.5% |
| Net Income | $2.92B | +13.7% |
| EPS (Basic) | $13.09 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.76B | +10.9% |
| Accounts Receivable | $3.24B | +4.7% |
| Inventory | $2.10B | +6.7% |
| Current Assets | $7.86B | +7.2% |
| Total Assets | $21.42B | +6.3% |
| Current Liabilities | $6.29B | +3.6% |
| Long-term Debt | $4.62B | -3.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.19B | +1.6% |
| Investing Cash Flow | -$640.0M | -13.7% |
| Financing Cash Flow | -$2.50B | -23.5% |
| +15.3% |
| EPS (Diluted) | $12.98 | +15.5% |
| Total Liabilities |
| $12.82B |
| +1.3% |
| Stockholders' Equity | $8.58B | +15.0% |